Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515045 · ClinicalTrials.gov registry record · Phase 4
Dropless vs. Standard Drops Contralateral Eye Study
A Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
- 4
- Study locations
NCT02515045 is a Phase 4 study of Cataract that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 59 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT02515045, a Phase 4 study of Cataract, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
- 4
- Study locations
Study Summary
To compare the use of an injectable compound containing an antibiotic and an anti-inflammatory at time of cataract surgery to standard of care that is the use 3 different topical medications to prevent inflammation and infection after routine cataract surgery.
Conditions Studied
Interventions
- DRUG TriMoxiVanc
- DRUG Moxifloxacin HCl 0.5%
- DRUG Ilevro
- DRUG Prednisolone acetate 1%
Study Locations (4)
Minnesota
- Minnesota Eye Consultants, P.A. - Bloomington
- Associated Eye Care - Stillwater
New York
- Ophthalmic Consultants of Long Island - Garden City
South Carolina
- Carolina Eyecare Physicians, LLC - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02515045
The ClinicalTrials.gov registry entry for NCT02515045 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower). The listed sponsor is Carolina Eyecare Physicians, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 4 interventions - of which TriMoxiVanc is the first listed.
NCT02515045 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, New York, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02515045 about?
NCT02515045 is a clinical study titled "Dropless vs. Standard Drops Contralateral Eye Study". To compare the use of an injectable compound containing an antibiotic and an anti-inflammatory at time of cataract surgery to standard of care that is the use 3 different topical medications to prevent inflammation and infection after routine cataract surgery.
What is the current status of trial NCT02515045?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2015-01. Estimated completion is 2016-03.
What conditions does trial NCT02515045 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT02515045?
The interventions under investigation include: TriMoxiVanc (DRUG), Moxifloxacin HCl 0.5% (DRUG), Ilevro (DRUG), Prednisolone acetate 1% (DRUG).
Who is sponsoring clinical trial NCT02515045?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02515045 being conducted?
This trial has 4 study locations across Minnesota, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.